VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Frankie Ann Holmes, MD
Published: Friday, Sep 01, 2017



Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.



Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x